文献速递头颈MR

1.5-T MR-linac系统下头颈部鳞状细胞癌表观扩散系数重测重现性评估

Test-Retest Apparent Diffusion Coefficient Reproducibility in Head and Neck Cancer Using a 1.5-T MR-Linac.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

本回顾性研究纳入37例头颈部鳞状细胞癌患者(34个原发灶、55个淋巴结),在放疗前两个时间点用1.5-T MR-linac采集扩散加权MRI,计算平均ADC和median ADC的绝对及百分比重现性系数。原发灶与淋巴结平均ADC的重现性系数分别为0.365×10⁻³ mm²/sec和0.355×10⁻³ mm²/sec,百分比重现性系数分别为29.9%和31.1%。重现性与病灶体积及扫描间隔无关,但观察到体积越小重现性越差的趋势。

要点

  • 原发灶平均ADC重现性系数0.365×10⁻³ mm²/sec,淋巴结为0.355×10⁻³ mm²/sec。
  • 原发灶平均ADC百分比重现性系数29.9%,淋巴结为31.1%。
  • 重现性与病灶体积及扫描间隔无关,但体积越小重现性越差的趋势被观察到。

核心结论

  • 该MR-linac序列对检测较大的ADC变化具有可接受的重现性,但可能仍会漏检部分有临床意义的变化。

研究设计与样本

  • 回顾性研究,2021年2月至2024年1月,37例头颈部鳞状细胞癌患者(36例男性、1例女性,中位年龄63岁,IQR 47-80岁),共34个原发灶和55个淋巴结;在放疗开始前两个时间点使用1.5-T MR-linac行平面回波扩散加权MRI;测量每个病灶的平均ADC、median ADC和体积,计算绝对及百分比重现性系数,并行线性回归分析和F检验。

诊断标准与关键数值

  • 原发灶平均ADC中位值1.19×10⁻³ mm²/sec(IQR 1.01-1.34×10⁻³ mm²/sec),淋巴结平均ADC中位值1.02×10⁻³ mm²/sec(IQR 0.88-1.33×10⁻³ mm²/sec)。
  • 原发灶median ADC中位值1.16×10⁻³ mm²/sec(IQR 0.99-1.36×10⁻³ mm²/sec),淋巴结median ADC中位值1.03×10⁻³ mm²/sec(IQR 0.90-1.35×10⁻³ mm²/sec)。
  • 原发灶体积中位值2.9 cm³(IQR 1.5-8.9 cm³),淋巴结体积中位值3.6 cm³(IQR 1.7-8.3 cm³)。
  • 原发灶平均ADC绝对重现性系数0.365×10⁻³ mm²/sec,淋巴结0.355×10⁻³ mm²/sec;原发灶百分比重现性系数29.9%,淋巴结31.1%;median ADC获得相似数值。

局限性

  • 该MR-linac序列对检测较大的ADC变化具有可接受的重现性,但可能仍会漏检部分有临床意义的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the reproducibility of apparent diffusion coefficient (ADC) measurements in head and neck squamous cell carcinoma (HNSCC) using a 1.5-T MR-linac (MRI-guided linear accelerator) system. Materials and Methods In this retrospective study, conducted between February 2021 and January 2024, patients with HNSCC lesions underwent echo-planar imaging diffusion-weighted MRI on a 1.5-T MR-linac system at two time points before the start of radiation therapy. Mean and median ADC values and volumes were measured for each lesion. Absolute and percent reproducibility coefficients (RCs) were calculated. Linear regression analyses and F tests were performed to determine whether the lesion volume or time between scans impacted reproducibility. Results The final cohort consisted of 37 patients (36 male, one female; median age, 63 years [IQR, 47-80 years]), with 34 primary tumors and 55 lymph nodes included in the analysis. For primary tumors and lymph nodes, the median of the mean ADC, median ADC, and volume were 1.19 × 10-3 mm2/sec (IQR, 1.01-1.34 × 10-3 mm2/sec) and 1.02 × 10-3 mm2/sec (IQR, 0.88-1.33 × 10-3 mm2/sec), 1.16 × 10-3 mm2/sec (IQR, 0.99-1.36 × 10-3 mm2/sec) and 1.03 × 10-3 mm2/sec (IQR, 0.90-1.35 × 10-3 mm2/sec), and 2.9 cm3 (IQR, 1.5-8.9 cm3) and 3.6 cm3 (IQR, 1.7-8.3 cm3), respectively. The respective RC values of mean ADC were 0.365 × 10-3 mm2/sec and 0.355 × 10-3 mm2/sec for tumors and lymph nodes, and the respective percent RC values were 29.9% and 31.1%; similar values were obtained for the median ADC. Reproducibility did not correlate with either the lesion volume or scan interval, but a trend toward poorer reproducibility with smaller volumes was observed. Conclusion This MR-linac sequence demonstrated acceptable reproducibility for detecting larger ADC changes but might still miss some clinically significant changes. Keywords: Radiation Therapy, MR-Diffusion Weighted Imaging, Radiation Therapy/Oncology, Head/Neck © RSNA 2026 Supplemental material is available for this article.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. McDonald BA, El-Habashy D, He R, et al. Test-Retest Apparent Diffusion Coefficient Reproducibility in Head and Neck Cancer Using a 1.5-T MR-Linac. Radiol Imaging Cancer. 2026. PMID: 41543375. doi:10.1148/rycan.250143

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。